| UniProt ID | ERLN2_HUMAN | |
|---|---|---|
| UniProt AC | O94905 | |
| Protein Name | Erlin-2 | |
| Gene Name | ERLIN2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 339 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type II membrane protein . Associated with lipid raft-like domains of the endoplasmic reticulum membrane. |
|
| Protein Description | Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs) such as ITPR1. [PubMed: 19240031] | |
| Protein Sequence | MAQLGAVVAVASSFFCASLFSAVHKIEEGHIGVYYRGGALLTSTSGPGFHLMLPFITSYKSVQTTLQTDEVKNVPCGTSGGVMIYFDRIEVVNFLVPNAVYDIVKNYTADYDKALIFNKIHHELNQFCSVHTLQEVYIELFDQIDENLKLALQQDLTSMAPGLVIQAVRVTKPNIPEAIRRNYELMESEKTKLLIAAQKQKVVEKEAETERKKALIEAEKVAQVAEITYGQKVMEKETEKKISEIEDAAFLAREKAKADAECYTAMKIAEANKLKLTPEYLQLMKYKAIASNSKIYFGKDIPNMFMDSAGSVSKQFEGLADKLSFGLEDEPLETATKEN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 18 | Phosphorylation | ASSFFCASLFSAVHK HHHHHHHHHHHHHHH | 31.00 | - | |
| 21 | Phosphorylation | FFCASLFSAVHKIEE HHHHHHHHHHHHHHC | 34.37 | - | |
| 34 | Phosphorylation | EEGHIGVYYRGGALL HCCCCEEEEECCEEE | 5.13 | 30576142 | |
| 61 | Phosphorylation | PFITSYKSVQTTLQT HHHHCCCCCCCEECC | 15.95 | 26437602 | |
| 106 | N-linked_Glycosylation | AVYDIVKNYTADYDK HHHHHHHHCCCCHHH | 28.61 | 17502376 | |
| 113 | Ubiquitination | NYTADYDKALIFNKI HCCCCHHHHHHHHHH | 38.57 | - | |
| 172 | Ubiquitination | IQAVRVTKPNIPEAI EEEEEECCCCHHHHH | 32.96 | - | |
| 190 (in isoform 1) | Ubiquitination | - | 61.31 | 21906983 | |
| 190 | Ubiquitination | YELMESEKTKLLIAA HHHHHCHHHHHHHHH | 61.31 | 2190698 | |
| 191 | Phosphorylation | ELMESEKTKLLIAAQ HHHHCHHHHHHHHHH | 23.91 | 25599653 | |
| 192 | Ubiquitination | LMESEKTKLLIAAQK HHHCHHHHHHHHHHH | 52.98 | - | |
| 199 | Ubiquitination | KLLIAAQKQKVVEKE HHHHHHHHHHHHHHH | 47.57 | - | |
| 228 | Phosphorylation | VAQVAEITYGQKVME HHHHHHHHHCCHHHH | 17.07 | 28152594 | |
| 229 | Phosphorylation | AQVAEITYGQKVMEK HHHHHHHHCCHHHHH | 24.18 | 28152594 | |
| 238 | Phosphorylation | QKVMEKETEKKISEI CHHHHHHHHHHHHHH | 65.26 | 25599653 | |
| 241 | Ubiquitination | MEKETEKKISEIEDA HHHHHHHHHHHHHHH | 45.28 | - | |
| 263 | Phosphorylation | AKADAECYTAMKIAE HHCCHHHHHHHHHHH | 6.77 | 22817900 | |
| 267 | Acetylation | AECYTAMKIAEANKL HHHHHHHHHHHHHCC | 35.98 | - | |
| 275 | Acetylation | IAEANKLKLTPEYLQ HHHHHCCCCCHHHHH | 52.50 | 25953088 | |
| 277 | Phosphorylation | EANKLKLTPEYLQLM HHHCCCCCHHHHHHH | 16.70 | - | |
| 280 | Phosphorylation | KLKLTPEYLQLMKYK CCCCCHHHHHHHHHH | 10.84 | 20049867 | |
| 285 | Acetylation | PEYLQLMKYKAIASN HHHHHHHHHHHHHCC | 52.79 | 25038526 | |
| 296 | Phosphorylation | IASNSKIYFGKDIPN HHCCCEEEECCCCCC | 15.26 | 22817900 | |
| 308 | Phosphorylation | IPNMFMDSAGSVSKQ CCCCHHCCCCHHHHH | 23.81 | 20860994 | |
| 311 | Phosphorylation | MFMDSAGSVSKQFEG CHHCCCCHHHHHHHH | 23.96 | 20860994 | |
| 313 | Phosphorylation | MDSAGSVSKQFEGLA HCCCCHHHHHHHHHH | 23.57 | 25693802 | |
| 322 | Ubiquitination | QFEGLADKLSFGLED HHHHHHHHHCCCCCC | 40.18 | - | |
| 334 | O-linked_Glycosylation | LEDEPLETATKEN-- CCCCCCCHHCCCC-- | 47.51 | 55829213 | |
| 336 | O-linked_Glycosylation | DEPLETATKEN---- CCCCCHHCCCC---- | 46.43 | 55829217 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ERLN2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ERLN2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERLN2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 611225 | Spastic paraplegia 18, autosomal recessive (SPG18) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "SPFH2 mediates the endoplasmic reticulum-associated degradation ofinositol 1,4,5-trisphosphate receptors and other substrates inmammalian cells."; Pearce M.M., Wang Y., Kelley G.G., Wojcikiewicz R.J.H.; J. Biol. Chem. 282:20104-20115(2007). Cited for: FUNCTION, SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-106, ANDMUTAGENESIS OF ASN-106. | |